Endo, Inc. (OTCQX: NDOI) announced today that it has entered into a definitive agreement with MC2 Therapeutics ("MC2") to commercialize Wynzora® Cream (calcipotriene ...
Endo, Inc. (OTCQX: NDOI) announced today that it has entered into a definitive agreement with MC2 Therapeutics ("MC2") to commercialize Wynzora® Cream ...
Arcutis Biotherapeutics has returned an impressive +200% YTD, following the successful product launch of Zoryve. See why I rate ARQT stock as a Strong Buy.
As the seasons change, your skin-care routine might need to change too. Prevent and soothe dry, irritated winter skin with ...
Around 30% of the population suffers from dry skin, and I’m definitely among them — especially in the brutally cold winter ...
While most people would be thrilled to get a pair of headphones or a new TV for the holidays, others might want something a ...